U.S. flag

An official website of the United States government

NM_000133.4(F9):c.364G>A (p.Gly122Arg) AND multiple conditions

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jun 8, 2020
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001327375.6

Allele description

NM_000133.4(F9):c.364G>A (p.Gly122Arg)

Gene:
F9:coagulation factor IX [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xq27.1
Genomic location:
Preferred name:
NM_000133.4(F9):c.364G>A (p.Gly122Arg)
HGVS:
  • NC_000023.11:g.139541162G>A
  • NG_007994.1:g.15427G>A
  • NM_000133.4:c.364G>AMANE SELECT
  • NM_001313913.2:c.277+3776G>A
  • NP_000124.1:p.Gly122Arg
  • LRG_556:g.15427G>A
  • NC_000023.10:g.138623321G>A
Protein change:
G122R
Links:
dbSNP: rs770120402
NCBI 1000 Genomes Browser:
rs770120402
Molecular consequence:
  • NM_001313913.2:c.277+3776G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000133.4:c.364G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary factor IX deficiency disease (HEMB)
Synonyms:
F9 DEFICIENCY; PLASMA THROMBOPLASTIN COMPONENT DEFICIENCY; Hemophilia B; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0010604; MeSH: D002836; MedGen: C0008533; Orphanet: 98879; OMIM: 306900
Name:
Thrombophilia, X-linked, due to factor 9 defect
Synonyms:
Thrombophilia, X-linked, due to factor IX defect
Identifiers:
MONDO: MONDO:0010432; MedGen: C2749016; OMIM: 300807

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001518450Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Jun 8, 2020)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Haemophilia B (sixth edition): a database of point mutations and short additions and deletions.

Giannelli F, Green PM, Sommer SS, Poon MC, Ludwig M, Schwaab R, Reitsma PH, Goossens M, Yoshioka A, Brownlee GG.

Nucleic Acids Res. 1996 Jan 1;24(1):103-18.

PubMed [citation]
PMID:
8594556
PMCID:
PMC145614

Haemophilia B: database of point mutations and short additions and deletions, fifth edition, 1994.

Giannelli F, Green PM, Sommer SS, Lillicrap DP, Ludwig M, Schwaab R, Reitsma PH, Goossens M, Yoshioka A, Brownlee GG.

Nucleic Acids Res. 1994 Sep;22(17):3534-46.

PubMed [citation]
PMID:
7937052
PMCID:
PMC308314
See all PubMed Citations (3)

Details of each submission

From Invitae, SCV001518450.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change replaces glycine with arginine at codon 122 of the F9 protein (p.Gly122Arg). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and arginine. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with F9-related conditions (PMID: 8594556). This variant is also known as G10478A in the literature. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. This variant disrupts the p.Gly122 amino acid residue in F9. Other variant(s) that disrupt this residue have been observed in individuals with F9-related conditions (PMID: 7937052), which suggests that this may be a clinically significant amino acid residue. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 5, 2024